Each year, 22,000 Americans – 1,200 in the Northwest – are diagnosed with a malignant brain tumor.

With a life expectancy of only 1-2 years, a brain cancer patient’s best chance for survival lies in receiving the most advanced medical treatments.

Thanks in part to the fundraising and advocacy efforts of groups like the Sammamish-based Chris Elliott Fund for Glioblastoma Brain Cancer Research, (CEF), that treatment is now available in Seattle.

The Center for Advanced Brain Tumor Treatment (CABTT) at the Swedish Neuroscience Institute provides hope to brain cancer patients and their families through ground-breaking research and patient-centered care.

The 2nd Annual Seattle Brain Cancer Walk on Saturday, May 30, is a benefit event that raises funds to support the important work of the CABTT.

CABTT offers new hope to brain cancer patients through access to the latest clinical trials, personalized treatment options based on a patient’s unique genetic make-up, and an integrated-care approach that improves outcomes and quality of life.

The Seattle Brain Cancer Walk presents an opportunity for brain cancer patients, their families and friends, and community supporters to gather around this important cause.

Event organizers hope to raise $200,000 for the CABTT, increase awareness about brain cancer within the greater Seattle community, and foster a much-needed patient and family network for brain cancer patients in the Pacific Northwest

For more information about walk please visit www.braincancerwalk.org.